{
    "Trade/Device Name(s)": [
        "QUANTA Flash\u00ae CCP3",
        "QUANTA Flash\u00ae CCP3 Calibrators",
        "QUANTA Flash\u00ae CCP3 Controls"
    ],
    "Submitter Information": "INOVA Diagnostics, Inc",
    "510(k) Number": "K143754",
    "Predicate Device Reference 510(k) Number(s)": [
        "K052264"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NHX",
        "JIT",
        "JJX"
    ],
    "Summary Letter Date": "August 19, 2015",
    "Summary Letter Received Date": "August 20, 2015",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.5775",
        "21 CFR 862.1150",
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Rheumatoid Factor Immunological Test System",
        "Calibrator",
        "Quality control material (assayed and unassayed)"
    ],
    "Analyte Class(es)": [
        "immunology",
        "autoimmune"
    ],
    "Analyte(s)": [
        "IgG anti-CCP3 antibodies"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "BIO-FLASH\u00ae instrument"
    ],
    "Method(s)/Technology(ies)": [
        "Chemiluminescent immunoassay"
    ],
    "Methodologies": [
        "Solid phase (heterogeneous) immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Calibrator",
        "Control",
        "Reagent",
        "Cartridge"
    ],
    "Document Summary": "FDA 510(k) summary for QUANTA Flash CCP3 chemiluminescent immunoassay and associated calibrators and controls for semi-quantitative determination of IgG anti-CCP3 antibodies using the BIO-FLASH instrument",
    "Indications for Use Summary": "Semi-quantitative determination of IgG anti-CCP3 antibodies in human serum as an aid in the diagnosis of rheumatoid arthritis, used in conjunction with clinical findings and other laboratory tests",
    "fda_folder": "Immunology"
}